Jingjing Li
Langfang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy, Safety, and Kinetics of Naturally Selected Anti-CD7 CAR-T Cell Therapy in T-ALL/LBL With CNS Leukemia.
Journal: American journal of hematology
Published: April 17, 2026
Long-Term Outcomes of Second Allogeneic Transplantation Following CD7 CAR-T in Remission for T-Cell Acute Lymphoblastic Leukemia or Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 16, 2026
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia.
Journal: Blood
Published: April 01, 2024
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T-cell therapy.
Journal: British journal of haematology
Published: January 25, 2024
Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.
Journal: Leukemia & lymphoma
Published: September 07, 2023
Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy.
Journal: American journal of hematology
Published: August 14, 2023
Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma.
Journal: Cells
Published: October 26, 2022
A novel adoptive synthetic TCR and antigen receptor (STAR) T-Cell therapy for B-Cell acute lymphoblastic leukemia.
Journal: American journal of hematology
Published: February 07, 2022
Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study.
Journal: Blood cancer journal
Published: January 28, 2022
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia.
Journal: Cancer immunology, immunotherapy : CII
Published: January 27, 2021
Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features.
Journal: Blood advances
Published: January 09, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026